A combination survival analysis revealed that patients with a high co-expression of ULBP1, AARS1, and DDIT3 exhibited a 2.2-fold increased risk of death from colon adenocarcinoma (COAD) compared to patients with a low expression of all three genes [48]. This evidence concerns the gene ULBP1 and colon adenocarcinoma.